There was some good news in the clinical sphere for Gilead Sciences ( GILD 2.74%) on Thursday, and this drove its stock price ...

As global markets rebound from recent sell-offs, with growth stocks notably outpacing value shares, the technology sector has ...

Since my last article, Gilead Sciences ... I'll present an analysis of the sales of its HIV and oncology franchises, the successes and failures in the development of its rich portfolio of next ...

We recently compiled a list of the 12 Best Biotech Stocks To Invest In According To Hedge Funds. In this article, we are ...

Our analysis of options history for Gilead Sciences GILD revealed 10 unusual ... with the core of its portfolio focused on HIV and hepatitis B and C. Gilead's acquisition of Pharmasset brought ...

The "Cell Therapy Manufacturing Market (6th Edition): Industry Trends and Global Forecasts to 2035 - Distribution by Type of Cell Therapy, Source of Cells, Scale of Operation, Type of Manufacturer and ...

In this article, we are going to take a look at where Gilead Sciences, Inc. (NASDAQ ... According to stock analysis, there are 665 stocks in the biotechnology industry, with a combined market ...

IBBQ is a relatively new US biotech ETF that competes with established peers like IBB and XBI. Read why I don't recommend ...

As we have mentioned in our article, “10 Best Penny Stocks to Buy Under $1," the size of the global biotechnology industry ...

Comparing Gilead Sciences, Inc. and AbbVie Inc’s grades, scores and metrics can act as a solid basis to determine whether they may be a good investment or not. You’ll also want to look at your ...

Comparing Gilead Sciences, Inc. and Bristol-Myers Squibb Co’s grades, scores and metrics can act as a solid basis to determine whether they may be a good investment or not. You’ll also want to look at ...